-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease.
-
Summary
-
Evelo Biosciences, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q4 2022.
- Evelo Biosciences, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2022 was $8.63M, a 26.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)